ES2656962T3 - Métodos para evaluar la receptividad del endometrio de una paciente - Google Patents

Métodos para evaluar la receptividad del endometrio de una paciente Download PDF

Info

Publication number
ES2656962T3
ES2656962T3 ES11725888.9T ES11725888T ES2656962T3 ES 2656962 T3 ES2656962 T3 ES 2656962T3 ES 11725888 T ES11725888 T ES 11725888T ES 2656962 T3 ES2656962 T3 ES 2656962T3
Authority
ES
Spain
Prior art keywords
endometrium
patient
receptivity
genes
biopsy sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11725888.9T
Other languages
English (en)
Spanish (es)
Inventor
Samir Hamamah
Delphine Haouzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Centre Hospitalier Universitaire de Montpellier
Universite de Montpellier
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Centre Hospitalier Universitaire de Montpellier
Universite de Montpellier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Centre Hospitalier Universitaire de Montpellier, Universite de Montpellier filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of ES2656962T3 publication Critical patent/ES2656962T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/42Gynaecological or obstetrical instruments or methods
    • A61B17/425Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
    • A61B17/435Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for embryo or ova transplantation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C40B40/08Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Transplantation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES11725888.9T 2010-05-27 2011-05-27 Métodos para evaluar la receptividad del endometrio de una paciente Active ES2656962T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10305561 2010-05-27
EP10305561 2010-05-27
US35431010P 2010-06-14 2010-06-14
US354310P 2010-06-14
PCT/EP2011/058757 WO2011147976A1 (en) 2010-05-27 2011-05-27 Methods for assessing endometrium receptivity of a patient

Publications (1)

Publication Number Publication Date
ES2656962T3 true ES2656962T3 (es) 2018-03-01

Family

ID=42396421

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11725888.9T Active ES2656962T3 (es) 2010-05-27 2011-05-27 Métodos para evaluar la receptividad del endometrio de una paciente

Country Status (6)

Country Link
US (1) US9260748B2 (enExample)
EP (1) EP2576825B1 (enExample)
JP (2) JP6219164B2 (enExample)
ES (1) ES2656962T3 (enExample)
PT (1) PT2576825T (enExample)
WO (1) WO2011147976A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2987446B1 (fr) * 2012-02-28 2016-01-01 Univ Nice Sophia Antipolis Test diagnostic de la resistance a l'azacitidine
EP2687851A1 (en) * 2012-07-20 2014-01-22 Matricelab Innove Method for increasing implantation success in assisted fertilization
EP3246036B1 (en) * 2014-10-28 2021-10-13 Koushi Yamaguchi Medicine for improving pregnancy-induced hypertension syndrome
US11541040B2 (en) 2014-10-28 2023-01-03 Kouchi Yamaguchi Medicine for improving state of pregnancy, and use thereof
JP6927890B2 (ja) * 2015-06-12 2021-09-01 ジェネア アイピー ホールディングス ピーティーワイ リミテッド 患者および生物学的試料の識別ならびに追跡のための方法およびシステム
CN105784983B (zh) * 2016-01-13 2017-10-31 深圳中山生殖与遗传研究所 一种评估子宫内膜容受性的试剂盒及其使用方法
US10918327B2 (en) 2017-02-02 2021-02-16 Coopersurgical, Inc. Compositions and methods for determining receptivity of an endometrium for embryonic implantation
IT201700045856A1 (it) * 2017-04-27 2018-10-27 Molipharma Srl Kit di determinazione della recettivita’ endometriale
EP3569718A1 (en) * 2018-05-16 2019-11-20 Integrated Genetic Lab Services SLU Kit and method for determining the receptivity status of an endometrium
WO2021160597A1 (en) * 2020-02-10 2021-08-19 ObsEva S.A. Biomarkers for oxytocin receptor antagonist therapy
CN111778326B (zh) * 2020-07-14 2021-10-22 和卓生物科技(上海)有限公司 用于子宫内膜容受性评估的基因标志物组合及其应用
JP2023136665A (ja) * 2022-03-17 2023-09-29 国立大学法人 東京大学 着床能の検出方法および着床障害の予測方法
EP4311862A1 (en) 2022-07-29 2024-01-31 Ivi Rma Global, Sl. Methods for detection of embryo implantation failure of endometrial origen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6196965B1 (en) * 1998-05-21 2001-03-06 Cryofacets, Inc. Compositions methods and devices for embryo implantation for in vitro fertilization
US7354742B2 (en) * 2002-02-22 2008-04-08 Ortho-Mcneil Pharmaceutical, Inc. Method for generating amplified RNA
FR2876701B1 (fr) 2004-10-15 2010-09-17 Genevrier Lab Procede de preparation d'un systeme de culture d'endometre autologue pour la co-culture endometre-embryon

Also Published As

Publication number Publication date
JP6219164B2 (ja) 2017-10-25
WO2011147976A1 (en) 2011-12-01
EP2576825B1 (en) 2017-11-08
JP2013528052A (ja) 2013-07-08
PT2576825T (pt) 2018-02-02
US20130072748A1 (en) 2013-03-21
EP2576825A1 (en) 2013-04-10
JP2016171802A (ja) 2016-09-29
US9260748B2 (en) 2016-02-16

Similar Documents

Publication Publication Date Title
ES2656962T3 (es) Métodos para evaluar la receptividad del endometrio de una paciente
ES2506116T3 (es) Nuevo biomarcador para diagnóstico, predicción y/o pronóstico de septicemia y usos del mismo
ES2484417T3 (es) Perfil de expresión génica como marcador de la receptividad endometrial
ES2687469T3 (es) Marcadores autoanticuerpos para el diagnóstico de traumatismo craneoencefálico
BR112013027124A2 (pt) método e sistema para analisar características de tecido
AR095363A1 (es) Biomarcadores y métodos para el tratamiento de condiciones relacionadas con pd-1 y pd-l1
BR112013003391B8 (pt) Método para diagnosticar câncer pancreático em um indivíduo
ES2530843T3 (es) Métodos basados en microARN para el diagnóstico de cáncer de páncreas
GB201300533D0 (en) Methods of monitoring conditions by sequence analysis
BR112012009481A2 (pt) método e dispositivo para detectar uma pluralidade de alvos em uma amostra biológica, e, kit para detectar uma pluralidade de alvos múltiplos em uma amostra biológica
WO2014201516A3 (en) Biomarker identification
BR112013006764A2 (pt) método para avaliar um paciente, kit, meio legível por computador, método para avaliar um tratamento, método para avaliar o risco de um paciente, método para monitorar, método de diagnosticar, sistema de teste, método para classificar ou agrupar uma população de indivíduos, método para avaliar um desfecho substituto, método para tratar, uso de pelo menos um biomarcador, uso de um agente
EP2319941A3 (en) Method and apparatus for correlating levels of biomarker products with disease
ECSP13013092A (es) Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo
EP3159695A3 (en) Methods for diagnosing pancreatic cancer
BR112018011224A2 (pt) processo de avaliação do risco de complicações nos pacientes que apresentam uma síndrome da resposta inflamatória sistêmica (sirs)
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
WO2017050939A3 (en) Method and array for diagnosing pancreatic cancer in an individual
MX2012007009A (es) Método para diagnosticar un tumor maligno.
BR112018073214A2 (pt) métodos para a previsão do risco de recorrência da fibrilação atrial, para o diagnóstico de fibrilação atrial em um indivíduo, para o monitoramento de uma terapia e para a classificação da fibrilação e utilizações do biomarcador
AR071034A1 (es) Uso de la catepsina c en el diagnostico de susceptibilidad al dolor y para el tratamiento del dolor
BR112014031957A2 (pt) bag3 como soro bioquímico e marcador de tecido
BR112016002709A2 (pt) queratinas como biomarcadores para câncer cervical e sobrevivência
PE20120592A1 (es) Metodo con biomarcadores para el seguimiento de un tratamiento
BR112022015578A2 (pt) Método para identificar um ou mais lipídios em uma amostra, dispositivo para identificar um ou mais lipídios em uma amostra, kit para identificar um ou mais lipídios em uma amostra e método para detectar a presença ou ausência de uma ou mais doenças ou condições médicas em um sujeito